TM vs TRDA · P/E 9.7, rev $234.60B vs P/E 12, rev $210.8M
Toyota Motor Corporation ADR (TM) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Toyota Motor Corporation ADR (TM) is a auto manufacturers company listed on NYSE.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported TM revenue for 2013-03-31 was $234.60B. Net income was $10.23B. Revenue was up 3.8% from 2012-03-31 to 2013-03-31. TM currently screens at market cap $211.00B and trailing P/E 9.7.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
TM currently screens at market cap $211.00B and trailing P/E 9.7. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the TM and TRDA stock pages for the full models.
Not investment advice.